Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.

Item
http://www.wikidata.org/entity/Q45866665
Cerebrolysin for vascular dementiaEffectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a reviewCerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke.Function and clinical meaningfulness of treatments for mild Alzheimer's disease.Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease.Successes and failures for drugs in late-stage development for Alzheimer's diseaseBeneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial.Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.Non-invasive diagnosis and treatment strategies for traumatic brain injury: an update.Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond
P2860

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.

Item
http://www.wikidata.org/entity/Q45866665
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@en
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@nl
type
label
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@en
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@nl
prefLabel
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@en
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Efficacy and safety of Cerebro ...... three dosages of Cerebrolysin.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1468-1331.2010.03092.X
P433
P478
P577
P5875
P698